Abstract
The plasma protein binding of 2-chloro-2′-deoxyadenosine (CdA) at 37°;C was studied by ultrafiltration in 5 healthy volunteers, in 11 patients with haematological malignancies and in purified protein preparations. In the patients, the binding of CdA to plasma proteins was 25.0% and in healthy subjects it was 21.1%. In a solution of human serum albumin (40 g·1−1), 24.3% CdA was bound, but less than 5% was bound in a solution of α1-acid-glycoprotein (0.7 g·1−1). No dependence of binding on the concentration of CdA was found within a range 25–1000 nmol·1−1.
In conclusion, due to its limited binding to plasma proteins, any change in the binding of CdA is unlikely to have a major influence on its pharmacological effect.
References
Bryson H, Storkin E (1993) Cladribine. A review of its pharmacodynamics, pharmacokinetics and therapeutic potential in the treatment of haematological malignancies. Drugs 46: 872–894
Albertioni F, Juliusson G, Liliemark J (1993) On the bioavailability of 2-chloro-2′-deoxyadenosine (CdA). The influence of food and omeprazole. Eur J Clin Pharmacol 44: 579–582
Liliemark J, Albertioni F, Hassan M, Juliusson G (1992) On the bioavailability of oral and subcutaneous 2-chloro-2′-deoxyadenosine in humans: alternative routes of administration. J Clin Oncol 10: 1514–1518
Liliemark J, Juliusson G (1991) On the pharmacokinetics of 2-chloro-2′-deoxyadenosine in humans. Cancer Res 51: 5570–5572
Steele W, Lawrence J, Stuart J, McNeil C (1981) The protein binding of methotrexate in the serum of patients with neoplastic disease. Cancer Chemother Pharmacol 17: 61–64
Clark I, Slevin M (1987) The clinical pharmacology of Etoposide and Teniposide. Clin Pharmacokinet 12: 223–252
Gibaldi M, Levy G, Newman P (1957) Effect of plasma protein and tissue binding on the biological half-life of drugs. Clin Pharmacol Ther 24: 1–4
Jusko W, Greth M (1976) The influence of protein binding of the drugs on pharmacokinetics. Drug Metabol Rev 5: 43–140
Liliemark J, Pettersson B, Juliusson G (1991) Determination of 2-chloro-2′-deoxyadenosine in human plasma. Biomed Chromatogr 5: 262–264
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Albertioni, F., Herngren, L., Juliusson, G. et al. Protein binding of 2-chloro 2′-deoxyadenosine (cladribine) in healthy subjects and in patients with leukaemia. Eur J Clin Pharmacol 46, 563–564 (1994). https://doi.org/10.1007/BF00196117
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196117